Hepatic Enzyme Profiles Before and after Antiretroviral Therapy among HIV-Seropositive Patients at Ebonyi State University Teaching Hospital: A Comparative Study

Background: Human immunodeficiency virus (HIV) infection and antiretroviral therapy (ART) may be associated with changes in liver-associated biochemical markers. Evaluating these markers is important for monitoring the health of people living with HIV and identifying potential biochemical abnormalities. Aim: This study assessed and compared alkaline phosphatase (ALP), aspartate aminotransferase (AST), and alanine aminotransferase (ALT) levels among HIV-seropositive patients receiving antiretroviral therapy. Methods: A comparative study was conducted involving 59 HIV-seropositive participants and 31 control participants. Serum ALP, AST, and ALT levels were evaluated before and after ART among the HIV-seropositive participants and compared with those of the control group. Descriptive statistics were used to summarize the results. Paired-samples and independent-samples t-tests were used to assess differences in mean enzyme levels, with statistical significance set at p < 0.05. Results: Among the HIV-seropositive participants, mean ALP decreased from 81.42 ± 50.22 to 49.15 ± 29.32 U/L, AST decreased from 13.34 ± 12.93 to 10.58 ± 7.33 U/L, and ALT decreased from 11.98 ± 6.96 to 9.22 ± 4.32 U/L after ART. The paired-samples t-test showed statistically significant reductions in ALP (t = −6.880, p < 0.001) and ALT (t = −2.939, p = 0.005), but not in AST (t = −1.469, p = 0.147). Compared with controls, pre-ART ALP levels were significantly higher among HIV-seropositive participants (t = 2.657, p = 0.009). However, differences in AST (p = 0.128) and ALT (p = 0.184) were not statistically significant. Conclusion: The study found significant differences in ALP levels between HIV-seropositive participants before ART and controls, as well as significant reductions in ALP and ALT following ART. These findings demonstrate changes in selected liver-associated biochemical markers among the study participants. However, the observed changes do not independently establish that ART caused the reductions or confirm improvement in overall liver function.

Authors

Institutions

Publication Details

Journal
International Journal of TROPICAL DISEASE & Health
Published
2026-11-21
DOI
https://doi.org/10.9734/ijtdh/2026/v47i111804
Primary Topic
HIV/AIDS drug development and treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Hepatic Enzyme Profiles Before and after Antiretroviral Therapy among HIV-Seropositive Patients at Ebonyi State University Teaching Hospital: A Comparative Study

Mudathir Qossim, Adetokunbo Ajala, Oniye Adesola Helen, Okoi Benedette Leko et al.
International Journal of TROPICAL DISEASE & Health
HIV/AIDS drug development and treatment
article

Hepatic Enzyme Profiles Before and after Antiretroviral Therapy among HIV-Seropositive Patients at Ebonyi State University Teaching Hospital: A Comparative Study

Mudathir Qossim, Adetokunbo Ajala, Oniye Adesola Helen, Okoi Benedette Leko, Yusuf Ahmed, Sambo Justice Ede
article en

Abstract

Background: Human immunodeficiency virus (HIV) infection and antiretroviral therapy (ART) may be associated with changes in liver-associated biochemical markers. Evaluating these markers is important for monitoring the health of people living with HIV and identifying potential biochemical abnormalities. Aim: This study assessed and compared alkaline phosphatase (ALP), aspartate aminotransferase (AST), and alanine aminotransferase (ALT) levels among HIV-seropositive patients receiving antiretroviral therapy. Methods: A comparative study was conducted involving 59 HIV-seropositive participants and 31 control participants. Serum ALP, AST, and ALT levels were evaluated before and after ART among the HIV-seropositive participants and compared with those of the control group. Descriptive statistics were used to summarize the results. Paired-samples and independent-samples t-tests were used to assess differences in mean enzyme levels, with statistical significance set at p < 0.05. Results: Among the HIV-seropositive participants, mean ALP decreased from 81.42 ± 50.22 to 49.15 ± 29.32 U/L, AST decreased from 13.34 ± 12.93 to 10.58 ± 7.33 U/L, and ALT decreased from 11.98 ± 6.96 to 9.22 ± 4.32 U/L after ART. The paired-samples t-test showed statistically significant reductions in ALP (t = −6.880, p < 0.001) and ALT (t = −2.939, p = 0.005), but not in AST (t = −1.469, p = 0.147). Compared with controls, pre-ART ALP levels were significantly higher among HIV-seropositive participants (t = 2.657, p = 0.009). However, differences in AST (p = 0.128) and ALT (p = 0.184) were not statistically significant. Conclusion: The study found significant differences in ALP levels between HIV-seropositive participants before ART and controls, as well as significant reductions in ALP and ALT following ART. These findings demonstrate changes in selected liver-associated biochemical markers among the study participants. However, the observed changes do not independently establish that ART caused the reductions or confirm improvement in overall liver function.

International Journal of TROPICAL DISEASE & HealthVol. 47(11)
Abubakar Tafawa Balewa University (NG), Osun State University (NG), Lead City University (NG)
HIV/AIDS drug development and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon